Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #296602 on NorthWest Biotherapeutics Inc (NWBO)
HappyLibrarian
07/24/20 3:33 PM
#296603 RE: Lorie3168 #296602
CherryTree1
07/24/20 3:49 PM
#296610 RE: Lorie3168 #296602
NWBO today announced that the data collection from all of the clincial trial sites for the Company's Phase 3 trial of DCVAX-L for Glioblastoma brain cancer (the "Trial") has completed and all the sites have signed off on the locking of their data.